Search

The Bann Laboratory focuses on discovering novel mechanistic targets to treat heart failure. We aim to identify regulators of cardiac cell fate reprogramming and regeneration as a molecular strategy to repair and heal the heart following injury.

The Bann Laboratory focuses on discovering novel mechanistic targets to treat heart failure. We aim to identify regulators of cardiac cell fate reprogramming and regeneration as a molecular strategy to repair and heal the heart following injury.

Skip to main content Effectiveness of Ultrasound and AFP for HCC Screening Ultrasound and alpha-fetoprotein (AFP) have long been cornerstones of hepatocellular carcinoma (HCC) screening in patients with cirrhosis. We have explored how ultrasound quality, operator variability, and patient characterist…

Skip to main content Health Care Delivery Research Efficient delivery of proven health care interventions plays a critical role in outcomes for patients at-risk and with HCC. We have shown that delays in diagnosis and treatment, fragmentation of care, and disparities in access can significantly impac…

Sun Lab publications.

Learn about the Gao Lab's research

Skip to main content Emerging Imaging Strategies for HCC Screening Advances in imaging also offer promising alternatives for HCC screening. For example, abbreviated MRI protocols maintain diagnostic accuracy while reducing patient burden and resource use; however, its use must be considered in the co…

Skip to main content Evaluation of Indeterminate Liver Lesions (LR-3 and LR-4) The Liver Imaging Reporting and Data System (LI-RADS) standardizes imaging interpretation for liver lesions. Our group has a particular interest in indeterminate liver lesions (LI-RADS-3 and LR-4), which present challenges…

Meet our Principal Investigator, Jinming Gao, Ph.D.

Read about IOTN i3 Center